1. Home
  2. CUE vs MLSS Comparison

CUE vs MLSS Comparison

Compare CUE & MLSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CUE
  • MLSS
  • Stock Information
  • Founded
  • CUE 2014
  • MLSS 1989
  • Country
  • CUE United States
  • MLSS United States
  • Employees
  • CUE N/A
  • MLSS N/A
  • Industry
  • CUE Biotechnology: Pharmaceutical Preparations
  • MLSS Industrial Specialties
  • Sector
  • CUE Health Care
  • MLSS Health Care
  • Exchange
  • CUE Nasdaq
  • MLSS Nasdaq
  • Market Cap
  • CUE 77.3M
  • MLSS 77.1M
  • IPO Year
  • CUE 2018
  • MLSS 1995
  • Fundamental
  • Price
  • CUE $1.07
  • MLSS $0.85
  • Analyst Decision
  • CUE Strong Buy
  • MLSS Buy
  • Analyst Count
  • CUE 5
  • MLSS 1
  • Target Price
  • CUE $5.00
  • MLSS $1.25
  • AVG Volume (30 Days)
  • CUE 378.2K
  • MLSS 224.6K
  • Earning Date
  • CUE 11-14-2024
  • MLSS 11-14-2024
  • Dividend Yield
  • CUE N/A
  • MLSS N/A
  • EPS Growth
  • CUE N/A
  • MLSS N/A
  • EPS
  • CUE N/A
  • MLSS N/A
  • Revenue
  • CUE $9,532,000.00
  • MLSS $8,877,010.00
  • Revenue This Year
  • CUE $105.39
  • MLSS N/A
  • Revenue Next Year
  • CUE N/A
  • MLSS $18.88
  • P/E Ratio
  • CUE N/A
  • MLSS N/A
  • Revenue Growth
  • CUE 149.53
  • MLSS N/A
  • 52 Week Low
  • CUE $0.45
  • MLSS $0.52
  • 52 Week High
  • CUE $3.20
  • MLSS $1.10
  • Technical
  • Relative Strength Index (RSI)
  • CUE 45.52
  • MLSS 51.84
  • Support Level
  • CUE $0.92
  • MLSS $0.77
  • Resistance Level
  • CUE $1.09
  • MLSS $0.87
  • Average True Range (ATR)
  • CUE 0.11
  • MLSS 0.07
  • MACD
  • CUE 0.00
  • MLSS -0.00
  • Stochastic Oscillator
  • CUE 45.71
  • MLSS 28.57

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune disease with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103 and others.

About MLSS Milestone Scientific Inc.

Milestone Scientific Inc is engaged in pioneering proprietary, technological systems, and solutions for the medical and dental markets. It develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetic. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. In addition, the company provides The Wand, a handpiece that allows dentists to provide painless injections for virtually various dental procedures, including routine cleanings and fillings, as well as implants, root canals, and crowns. The Company conducts its business through two reportable segments: Dental and Medical. Geographically all the operations of the firm function through the region of the U.S.

Share on Social Networks: